tiprankstipranks
Trending News
More News >
Standard BioTools (LAB)
NASDAQ:LAB

Standard BioTools (LAB) Revenue

Compare
446 Followers

Standard BioTools Revenue

Standard BioTools had a revenue of 46.72M in the quarter ending Dec 31, 2024, with 3.89%. This bring the company's revenue in the last twelve months to 174.43M, Decreased 11.89%. In the fiscal year ending Dec 31, 2024, Standard BioTools had annual revenue of 174.43M with 64.03% growth.
Revenue (ttm)
174.43M
Revenue Growth
33.86%
P/S Ratio
2.53
Revenue/Employee
$214,290
Employees
814
Market Cap
$440.59M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
174.43M68.09M+64.03%
Dec 31, 2023
106.34M8.39M+8.57%
Dec 31, 2022
97.95M-32.63M-24.99%
Dec 31, 2021
130.58M-7.56M-5.47%
Dec 31, 2020
138.14M20.90M+17.83%
Dec 31, 2019
117.24M4.28M+3.79%
Dec 31, 2018
112.96M11.03M+10.82%
Dec 31, 2017
101.94M-2.51M-2.40%
Dec 31, 2016
104.45M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis